What You Should Know:
– Hippocratic AI, the global leader in safety-focused generative AI agents for healthcare, today announced a partnership with EUCALIA Inc., a Tokyo-based healthcare transformation company focused on optimizing clinical operations and advancing care delivery, to launch the first Japanese-language generative AI healthcare agent for non-diagnostic, patient-facing clinical tasks.
– This marks Hippocratic AI’s entry into the Japanese market, further advancing its global mission to deliver healthcare abundance through technology.
Hippocratic AI and EUCALIA Partner to Launch Japan’s First Safety-Focused Generative AI Healthcare Agent
Hippocratic AI has partnered with EUCALIA to introduce a generative AI healthcare agent in Japan, designed to enhance patient access and ease clinician workload in a healthcare system facing rising demand, an aging population, and workforce constraints. The agent will handle essential, non-diagnostic, patient-facing responsibilities—including appointment scheduling, medication adherence support, chronic care check-ins, and follow-up outreach—enabling clinicians to focus on core care tasks.
At the core of this solution is Hippocratic AI’s Polaris Constellation System, a patented safety-first architecture built specifically for high-empathy, medically accurate conversations. The system has:
- Powered over 1.85 million patient calls in the U.S.
- Achieved a clinical accuracy rate of 99.38%
- Reached a patient experience rating of 8.95/10
- Been adopted by more than 25 enterprise healthcare partners
This architecture includes a series of specialized supervisor models that oversee medication discussions, lab results, nutrition, vitals, escalation protocols, and hospital-specific policies—ensuring safe and tailored patient engagement at scale.
The collaboration builds on Hippocratic AI’s founding mission to bring healthcare expertise to every human through safe, accessible AI. Co-founded by CEO Munjal Shah alongside clinicians, hospital administrators, and AI experts from institutions like Stanford, Johns Hopkins, Microsoft, and NVIDIA, the company has focused on setting new global standards for clinical AI safety.
“This partnership with EUCALIA reflects our commitment to building generative AI agents that are not just multilingual but locally fluent, clinically safe, and culturally aligned,” said Shah. “Together, we aim to deliver meaningful improvements in patient outcomes, clinical operations, and system resilience.”
By combining Hippocratic AI’s robust technology with EUCALIA’s local healthcare insight, the partnership aims to create a scalable, culturally competent solution that enhances efficiency, empathy, and accessibility across Japan’s healthcare landscape.
